Ultreia Capital Overview

  • Investor Type
  • Venture Capital
  • Status
  • Inactive
  • Investments
  • 30
  • Portfolio
  • 2
  • Exits
  • 30
Exits

Ultreia Capital General Information

Description

Ultreia Capital was venture capital firm that used to specialize in the life science sectors.

Contact Information

Investor Status
Out of Business
Primary Investor Type
Venture Capital
Primary Office
  • Schutzengasse 25
  • P.O. Box 1310
  • 8021 Zurich
  • Switzerland

Ultreia Capital Investments (30)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Affinium Pharmaceuticals 30-Aug-2013 Later Stage VC 000.00 Pharmaceuticals Out of Business
000000000 16-Nov-2010 00000 00000 0000 Diagnostic Equipment Profitable
00000000 08-Jun-2010 00000000000 00.00 Biotechnology Profitable
000000 29-Jan-2010 00000 00000 00000 Diagnostic Equipment Out of Business
00000000 07-Aug-2008 00000 00000 000.00 Pharmaceuticals Generating Revenue
0000000 0000000000 16-Apr-2008 00000 00000 000.00 Pharmaceuticals Generating Revenue/Not Profitable
00000 00000 000000 30-Jun-2005 00000 00000 000.00 Drug Discovery Generating Revenue
00000000 000000000 01-Apr-2005 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 3
Predix Pharmaceuticals Holdings 25-Jan-2005 Later Stage VC 0000 Drug Discovery Clinical Trials - Phase 2
CEPTYR 31-Oct-2003 Later Stage VC 000.00 Biotechnology Out of Business
You’re viewing 10 of 30 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ultreia Capital Exits (30)

Company Name Exit Date Exit Type Exit Size
Light Chain Bioscience 01-Jun-2021 Secondary Transaction - Private
00000000 01-Nov-2020 0000000000: 000000
0000000 0000000000 30-Oct-2014 0000000 000000 0000
000000 01-Oct-2014 000 00 00000000
00000000 000000000 11-Feb-2014 000000000000000000
000 000000 01-Apr-2012 00000000 000000 00
000000 31-Mar-2012 0000000000: 000000
000000 00000000000 23-Nov-2011 000000000000000000 00000
Kalypsys 01-Jan-2011 Bankruptcy: Liquidation
diaDexus 28-Jul-2010 Reverse Merger 000.00
You’re viewing 10 of 30 exits. Get the full list »

Ultreia Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial